Leap Therapeutics


Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.

Industries

Employees

11-50

Links


Org chart

Douglas Onsi
President, CEO, CFO, Board Member
Collapse
Mark O'Mahony
Chief Manufacturing Officer
Gus Lawlor
Chief Operating Officer
Matthew Lederhos
Vp, Finance & Corporate Controller
Mike Kagey
Vice President Of Translational Medicine
Jonathan Miller
Vice President, Business Development & Finance
Xieyang Jia
Senior Director

Board & advisors